Protein expression changes in spinal muscular atrophy revealed with a novel antibody array technology.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Brain : a journal of neurology

• Publication date

  2003-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/BRAIN/AWG208PMID 12847076
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recent developments in DNA microarrays.

  2002cited by this paper
• The SMN complex, an assemblyosome of ribonucleoproteins.

  2002cited by this paper
• Having it both ways: transcription factors that bind DNA and RNA.

  2002cited by this paper
• Critical roles of phosphorylation and actin binding motifs, but not the central proline-rich region, for Ena/vasodilator-stimulated phosphoprotein (VASP) function during cell migration.

  2002cited by this paper
• Mapping and Structural Dissection of Human 20 S Proteasome Using Proteomic Approaches*

  2002cited by this paper
• A Direct Interaction between the Survival Motor Neuron Protein and p 53 and Its Relationship to Spinal Muscular Atrophy *

  2002cited by this paper
• A Direct Interaction between the Survival Motor Neuron Protein and p53 and Its Relationship to Spinal Muscular Atrophy*

  2002cited by this paper
• Ligand-induced, receptor-mediated dimerization and activation of EGF receptor.

  2002cited by this paper
• Direct Interaction of the Spinal Muscular Atrophy Disease Protein SMN with the Small Nucleolar RNA-associated Protein Fibrillarin*

  2001cited by this paper
• Spinal muscular atrophy disrupts the interaction of ZPR1 with the SMN protein

  2001cited by this paper
• Phosphorylation of proteins and apoptosis induced by c-Jun N-terminal kinase1 activation in rat cardiomyocytes by H(2)O(2) stimulation.

  2001cited by this paper
• A Functional Interaction between the Survival Motor Neuron Complex and RNA Polymerase II

  2001cited by this paper
• The survival of motor neurons (SMN) protein interacts with the snoRNP proteins fibrillarin and GAR1.

  2001cited by this paper
• Deletion of Murine SMN Exon 7 Directed to Skeletal Muscle Leads to Severe Muscular Dystrophy

  2001cited by this paper
• The relationship between SMN, the spinal muscular atrophy protein, and nuclear coiled bodies in differentiated tissues and cultured cells.

  2000cited by this paper
• Apoptotic and Growth-Promoting Activity of E2F Modulated by MDM2

  2000cited by this paper
• The core meiotic transcriptome in budding yeasts

  2000cited by this paper
• Characterization of the Schizosaccharomyces pombe orthologue of the human survival motor neuron (SMN) protein.

  2000cited by this paper
• Systematic variation in gene expression patterns in human cancer cell lines

  2000cited by this paper
• Animal models of spinal muscular atrophy.

  2000cited by this paper
• Disruption of SMN function by ectopic expression of the human SMN gene in Drosophila

  2000cited by this paper
• Direct interaction of Smn with dp103, a putative RNA helicase: a role for Smn in transcription regulation?

  2000cited by this paper
• Gemin3: A novel DEAD box protein that interacts with SMN, the spinal muscular atrophy gene product, and is a component of gems.

  1999cited by this paper
• The Caenorhabditis elegans orthologue of the human gene responsible for spinal muscular atrophy is a maternal product critical for germline maturation and embryonic viability.

  1999cited by this paper
• A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy.

  1999cited by this paper
• [Ameloblastic fibrosarcoma: an immunohistochemical and ultrastructural study of the mesenchymal component].

  1999cited by this paper
• A Role for Polyproline Motifs in the Spinal Muscular Atrophy Protein SMN

  1999cited by this paper
• Ischemic preconditioning mediated by activation of KATP channels in rat small intestine.

  1999cited by this paper
• Identification of survival motor neuron as a transcriptional activator-binding protein.

  1999cited by this paper
• The distribution of SMN protein complex in human fetal tissues and its alteration in spinal muscular atrophy.

  1998cited by this paper
• Regulation of Mdm2-Directed Degradation by the C Terminus of p53

  1998cited by this paper
• SMN oligomerization defect correlates with spinal muscular atrophy severity

  1998cited by this paper
• Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos.

  1997cited by this paper
• Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy

  1997cited by this paper
• cDNA isolation, expression, and chromosomal localization of the mouse survival motor neuron gene (Smn).

  1997cited by this paper
• The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis.

  1997cited by this paper
• The mdm2 proto-oncogene.

  1997cited by this paper
• Degeneration of cocultures of spinal muscular atrophy muscle cells and rat spinal cord explants is not due to secreted factors and cannot be prevented by neurotrophins

  1997cited by this paper
• The survival motor neuron protein in spinal muscular atrophy.

  1997cited by this paper
• A novel nuclear structure containing the survival of motor neurons protein.

  1996cited by this paper
• Constitutive muscular abnormalities in culture in spinal muscular atrophy.

  1995cited by this paper
• Identification and characterization of a spinal muscular atrophy-determining gene

  1995cited by this paper
• Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy.

  1978cited by this paper

• Analysis of Free Circulating Messenger Ribonucleic Acids in Serum Samples from Late-Onset Spinal Muscular Atrophy Patients Using nCounter NanoString Technology

  2023cites this paper
• Neurological Diseases in Pediatric Critical Care

  2021cites this paper
• Intracellular pathways involved in cell survival are deregulated in mouse and human spinal muscular atrophy motoneurons.

  2021cites this paper
• Molecular Factors Involved in Spinal Muscular Atrophy Pathways as Possible Disease-modifying Candidates

  2018cites this paper
• Pharmacological c-Jun NH2-Terminal Kinase (JNK) Pathway Inhibition Reduces Severity of Spinal Muscular Atrophy Disease in Mice

  2018cites this paper
• Axonal and Neuromuscular Junction Pathology in Spinal Muscular Atrophy

  2017cites this paper
• Genetic inhibition of JNK 3 ameliorates spinal muscular atrophy

  2015cites this paper
• Genetic inhibition of JNK3 ameliorates spinal muscular atrophy.

  2015cites this paper
• The human milk oligosaccharide 2′-fucosyllactose modulates CD14 expression in human enterocytes, thereby attenuating LPS-induced inflammation

  2014cites this paper
• Mechanisms of disease pathogenesis in Spinal Muscular Atrophy

  2014cites this paper
• Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease.

  2013cites this paper
• Amplification of MPZL1/PZR promotes tumor cell migration through Src-mediated phosphorylation of cortactin in hepatocellular carcinoma

  2013cites this paper
• A novel function for the survival motoneuron protein as a translational regulator.

  2013cites this paper
• Spinal Muscular Atrophy and the Antiapoptotic Role of Survival of Motor Neuron (SMN) Protein

  2013cites this paper
• Neurological Diseases in Pediatric Critical Care Medicine

  2012cites this paper
• Antibody microarray-based cellular oncoproteomics

  2012cites this paper
• Antibody Microarrays in Proteome Profiling

  2011cites this paper
• Reversible molecular pathology of skeletal muscle in spinal muscular atrophy.

  2011cites this paper
• Antibody Array as a Tool for Tumor Progression Study

  2011cites this paper
• High-throughput screen of protein expression levels induced by cyclooxygenase-2 during influenza a virus infection.

  2011cites this paper
• Proteomic assessment of a cell model of spinal muscular atrophy

  2011cites this paper
• Analysis conditions for proteomic profiling of mammalian tissue and cell extracts with antibody microarrays

  2010cites this paper
• Review: Neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy

  2010cites this paper
• How do kidney cells adapt to survive in hypertonic inner medulla?

  2009cites this paper
• Applying proteomics to the diagnosis and treatment of ALS and related diseases

  2009cites this paper
• Combination of mRNA and protein microarray analysis in complex cell profiling.

  2009cites this paper
• Antibody arrays for determination of relative protein abundances.

  2008cites this paper
• Protein Arrays and Fluorescence Detection: Applications and Limitations

  2008cites this paper
• Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy.

  2008cites this paper
• Protein biomarkers for amyotrophic lateral sclerosis

  2008cites this paper
• Upregulation of beta-catenin levels in superior frontal cortex of chronic alcoholics.

  2008cites this paper
• Investigating copper‐regulated protein expression in Menkes fibroblasts using antibody microarrays

  2008cites this paper
• Identification and characterisation of a nuclear localisation signal in the SMN associated protein, Gemin4.

  2008cites this paper
• Genetic network and pathway analysis of differentially expressed proteins during critical cellular events in fracture repair

  2007cites this paper
• Proteomic expression profiling of thyroid neoplasms

  2007cites this paper
• Histologic and transcriptional assessment of a mild SMA model

  2007cites this paper
• Traumatic brain injury stimulates hippocampal catechol-O-methyl transferase expression in microglia.

  2007cites this paper
• The tight junction protein, MUPP1, is up-regulated by hypertonicity and is important in the osmotic stress response in kidney cells

  2007cites this paper
• Insights on signal transduction pathways involved in familial amyloidotic polyneuropathy neurodegeneration

  2006cites this paper
• Nutrigenomics and nutrigenetics: the ‘omics’ revolution in nutritional science

  2006cites this paper
• Parallel and miniaturised Analysis of Protein-Protein Interactions in T-Cell Signal Transduction by Fluorescence Cross-Correlation Spectroscopy and Peptide Microarrays

  2006cites this paper
• Successful Development of a Flow Cytometric Assay to Analyze Cytokine-Induced Phosphorylation Pathways [CIPP] Within Peripheral Blood Leukocytes

  2006cites this paper
• Identification of differential protein expression associated with development of unstable human carotid plaques.

  2006cites this paper
• Signal stability of Cy3 and Cy5 on antibody microarrays

  2006cites this paper
• A chip‐based miniaturized format for protein‐expression profiling: The exploitation of comprehensively produced antibodies

  2006cites this paper
• Profiling of differential protein expression in angiogenin‐induced HUVECs using antibody‐arrayed ProteoChip

  2006cites this paper
• Label-free detection of proteins in crude cell lysate with antibody arrays by a surface plasmon resonance imaging technique.

  2005cites this paper
• Experimental design and analysis of antibody microarrays: applying methods from cDNA arrays.

  2005cites this paper
• Calpains in muscle wasting.

  2005cites this paper
• Determination of relative protein abundance by internally normalized ratio algorithm with antibody arrays.

  2005cites this paper
• Genomics, Proteomics, and Neurology

  2005cites this paper
• Progress in protein and antibody microarray technology.

  2005cites this paper
• Peptide microarrays for the detection of molecular interactions in cellular signal transduction

  2005cites this paper
• Protein Arrays in Functional Genome Research

  2005cites this paper
• Combined Oligonucleotide and Protein Microarray Temporal Analysis of p53-mediated Apoptosis

  2005cites this paper
• Neuromuscular disease: muscle

  2004cites this paper